出处
《腹部外科》
2007年第3期186-187,共2页
Journal of Abdominal Surgery
基金
卫生部临床学科重点项目(2004-2006-2)
二级参考文献17
-
1Sonoda K, Nakashima M, Kaku T, Kamura T, Nakano H,Watanabe T. A novel tumor-associated antigen expressed in human uterine and ovarian carcinomas. Cancer 1996; 77:1501-1509.
-
2Nakashima M, Sonoda K, Watanabe T. Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigen RCAS1. Nature Medicine 1999; 5:938-542.
-
3Kaku T, Sonoda K, Kamura T, Hirakawa T, Sakai K, AmadaS, Ogawa S, Kobayashi H, Nakashima M, Watanabe T,Nakano H. The prognostic significance of tumor-associated antigen 22-1-1 expression in adenocarcinoma of the uterine cervix. Clinical Cancer Res 1999; 5:1449-1453.
-
4Sonoda K, Kaku T, Hirakawa T, Kobayashi H, Amada S,Sakai K, Nakashima M, Watanabe T, Nakano H. The clinicalsignificance of tumor-associated antigen RCAS1 expression in the normal, hyperplastic, and malignant uterine endometrium.Gynecol Oncol 2000; 79:424-429.
-
5Takahashi H, Iizuka H, Nakashima M, Wada T, Asano K,Ishida-Yamamoto A, Watanabe T. RCAS1 antigen is highly expressed in extramammary Paget's disease and in advanced stage squamous cell carcinoma of the skin. J Dermatol Sci 2001; 26:140-144.
-
6Suzuki T, Inoue S, Kawabata W, Akahira J, Moriya T,Tsuchiya F, Ogawa S, Muramatsu M, Sasano H. EBAG9/RCAS1 in human breast carcinoma: a possible factor in endocrine-immune interactions. Br J Cancer 2001; 85:1731-1737.
-
7Tsuneizumi M, Nagai H, Harada H, Kazui T, Emi M. Ahighly polymorphic CA repeat marker at the EBAG9/RCAS1 locus on 8q23 that detected frequent multiplication in breast cancer. Ann Human Biol 2002; 29:457-460.
-
8Noguchi K, Enjoji M, Nakamuta M, Nakashima M, Nishi H,Choi I, Taguchi K, Kotoh K, Shimada M, Sugimachi K,Tsuneyoshi M, Nawata H, Watanabe T. Expression of a tumor-associated antigen RCAS1 in hepatocellular carcinoma.Cancer Lett 2001; 168:197-202.
-
9Oshikiri T, Hida Y, Miyamoto M, Hashida H, Katoh K,Suzuoki M, Nakakubo Y, Hiraoka K, Shinohara T, Itoh T,Kondo S, Katoh H. RCAS1 as a tumour progression marker:an independent negative prognostic factor in gallbladder cancer. Br J Cancer 2001; 85:1922-1927.
-
10Kubokawa M, Nakashima M, Yao T, Ito KI, Harada N,Nawata H, Watanabe T. Aberrant intracellular localization of RCAS1 is associated with tumor progression of gastric cancer. International J Oncol 2001; 19:695-700.
共引文献11
-
1程晶娟,白明.肿瘤相关抗原RCAS1与恶性肿瘤的关系[J].肿瘤防治研究,2006,33(6):468-470. 被引量:1
-
2曲佳,张伟华.表达于SiSo细胞上的受体结合性癌抗原的研究进展[J].白血病.淋巴瘤,2007,16(2):152-154.
-
3裘正军,刘俊.胰腺癌相关生物活性标志物研究[J].中华普通外科学文献(电子版),2009,3(3):4-7.
-
4杨盈赤,赵玉沛,廖泉,张太平,胡亚,戴梦华.RCAS1在胰腺癌诊断中的作用[J].中华外科杂志,2009,47(13):999-1001. 被引量:12
-
5廖泉,赵玉沛.血清肿瘤标志物在胰头部肿块鉴别诊断中的作用[J].中国实用外科杂志,2009,29(8):628-630. 被引量:3
-
6耿瑞慧,李淑德,李兆申.SiSo细胞表达的受体结合型癌抗原基因与胰腺癌[J].中华胰腺病杂志,2010,10(1):66-68.
-
7曾林山,肖卫东,李勇.胰腺癌血清肿瘤标志物的研究现状[J].国际外科学杂志,2010,37(12):839-843. 被引量:6
-
8王凯,石欣,黄毅,黄聪.肿瘤标志物对胰腺癌诊断的研究进展[J].东南大学学报(医学版),2011,30(5):793-796. 被引量:5
-
9徐春华,于力克,王清波.非小细胞肺癌患者血清RCAS1水平检测临床意义分析[J].中华肿瘤防治杂志,2013,20(5):347-349. 被引量:3
-
10赵琳.胰腺癌相关血清学肿瘤标志物的研究现状(综述)[J].中国城乡企业卫生,2013,28(6):24-27.
同被引文献58
-
1陈阵.胰头部肿块型胰腺炎的CT诊断[J].河南外科学杂志,2010,16(4):71-72. 被引量:2
-
2邵永孚.胰腺癌的分期及其依据[J].临床外科杂志,2005,13(4):198-199. 被引量:7
-
3赵玉沛.2005年普通外科进展的回顾与展望[J].中国实用外科杂志,2006,26(5):321-327. 被引量:46
-
4刘龙飞,卜双龙,彭秀达,李安文.重症胰腺炎合并肺损伤的治疗体会(附36例报告)[J].肝胆胰外科杂志,2007,19(3):184-185. 被引量:7
-
5Goldstein D,Carroll S, Apte M, et al. Modern management of pancreatic carcinoma. Intern Med J, 2004,34:475-481.
-
6Lygidakis NJ, Jain S, Apte M, et al. Adenocarcinoma of the pancreas-past, present and future. Hepato Gastroenterology, 2005, 52:1281-1291.
-
7Chua, YJ, Cunningham D. Adjuvant treatment for resectable pancreatic cancer. J Clin Oncol, 2005,23:4532-4537.
-
8Goggins M. Molecular markers of early pancreatic cancer. J Clin Oncol,2005,23: 4524- 4531.
-
9Lowenfels AB, Maisonneuve P. Risk factors for pancreatic cancer. J Cell Biochem, 2005,95 : 649-656.
-
10Michaud DS. Epidemiology of pancreatic cancer. Mineva Chir, 2004,59: 99-111.
引证文献3
-
1王树钢,费立明,于巍巍.早期胰腺癌的诊断方法[J].中华消化杂志,2009,29(2):141-144.
-
2廖泉,赵玉沛.慢性胰腺炎外科治疗难点探讨[J].中华普外科手术学杂志(电子版),2011,5(1):20-22. 被引量:6
-
3伦增军,黄勇.胰头部肿块型慢性胰腺炎20例回顾分析[J].中华普外科手术学杂志(电子版),2013,7(1):54-56.
二级引证文献6
-
1郭石,艾福录.胰腺癌手术治疗预后因素分析[J].中华普外科手术学杂志(电子版),2012,6(3):44-46. 被引量:3
-
2伦增军,黄勇.胰头部肿块型慢性胰腺炎20例回顾分析[J].中华普外科手术学杂志(电子版),2013,7(1):54-56.
-
3吴新民.慢性胰腺炎治疗中外科手术的选择[J].中国普外基础与临床杂志,2013,20(2):117-120. 被引量:1
-
4卢正嘉.慢性胰腺炎的外科治疗及术式评价[J].中国继续医学教育,2015,7(7):89-90. 被引量:1
-
5王坚,陈炜.如何提高肝胆胰手术的安全性[J].世界华人消化杂志,2016,24(34):4542-4548. 被引量:8
-
6周雪峰,钟海.内镜下治疗慢性胰腺炎的临床疗效及对患者腹痛症状改善程度的研究[J].中国内镜杂志,2017,23(10):83-86. 被引量:7
-
1宋婕,李官成.肝癌相关肿瘤标志物研究新进展[J].国际病理科学与临床杂志,2011,31(1):54-58. 被引量:12
-
2傅央波,陆枫林.肝细胞肝癌血清标志物的研究进展[J].东南大学学报(医学版),2011,30(4):662-666. 被引量:4
-
3孙艳虹,姜傥.肿瘤标志物在临床上的应用(中)[J].新医学,2008,39(2):126-127. 被引量:11
-
4步静芸.血清CEA、CA50、CA19-9和SA联检对直肠癌的诊断价值[J].放射免疫学杂志,2012,25(6):626-627. 被引量:1
-
5顾宇,陆枫林.肝癌标记物的研究进展[J].现代医学,2009,37(1):76-79. 被引量:5
-
6王玉珍,张占书,郭红亮.恶性肿瘤病人化学治疗的护理[J].长治医学院学报,2000,14(1):70-71. 被引量:1
-
7姜和.美国癌症研究的最新进展[J].中国高新技术企业,1998(3):58-59.
-
8赵旭,李安庆,于刚,王林忠.原发性肝癌的血清肿瘤标记物研究[J].肝胆外科杂志,2011,19(4):278-280.
-
9陈浙涌.5种血清肿瘤标志物联检用于胃癌的辅助诊断[J].放射免疫学杂志,2013,26(5):651-652. 被引量:2
-
10余朝亚.血清四种肿瘤标志物联检在胰腺癌早期诊断的临床应用[J].放射免疫学杂志,2011,24(1):102-103.